Constitutive expression of a CD44 variant isoform on T cells facilitates regaining of immunocompetence in allogeneic bone marrow transplantation

Blood

Volumn 90, Issue 2, 1997, Pages 873-885

  Zöller, Margot ^a   Schmidt, Annette ^b   Denzel, Angela ^b   Moll, Jürgen ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0343479607     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.2.873     Document Type: Article

References (82)

1. Thomas ED: Frontiers in bone marrow transplantation. Blood Cells 17:259, 1991
2. Bortin MM, Rimm AA: Increasing utilization of bone marrow transplantation. Transplantation 42:229, 1986
3. Korsmeyer SJ, Elfenbaum GJ, Goldman CK, Marshall SL, Waldmann TA: B cell, helper cell and suppressor cell abnormalities contribute to disordered immunoglobulin synthesis in patients following bone marrow transplantation. Transplantation 33:184, 1982
4. Zander AR, Reyben JM, Johnston D, Vellekoop L, Dicke KA, Yan JC, Hersh EM: Immune recovery following allogeneic bone marrow transplantation. Transplantation 40:177, 1985
5. Paulin T, Ringden O, Nilsson B: Immunological recovery after bone marrow transplantation. Role of age, graft-versus-host disease, prednisolone treatment and infections. Bone Marrow Transplant 1:317, 1987
6. Witherspoon RP, Storb R, Ochs HD, Flournoy N, Kopecky KJ, Sullivan KM, Deeg HJ, Sosa R, Noel DR, Atkinson C, Thomas ED: Recovery of antibody production in human allogeneic marrow graft recipients: Influence of time post-transplantation, the presence or absence of chronic graft-vs-host disease and anti-thymocyte globulin treatment. Blood 58:360, 1981
7. Witherspoon RP, Deeg HJ, Lum L, Ochs HD, Hansen JA, Thomas ED, Storb R: Immunological recovery in human marrow graft recipients given cyclosporin or methotrexate for the prevention of graft-versus-host disease. Transplantation 37:456, 1984
8. Geppert TD, Davis LS, Gur H, Wacholtz MC, Lipsky PE: Accessory cell signals involved in T cell activation. Immunol Rev 117:5, 1990
9. Omary MB, Trowbridge IS, Letarte M, Kagnoff MF, Isacke CM: Structural heterogeneity of human Pgp-1 and its relationship with p85. Immunogenetics 27:460, 1988
10. Idzerda RL, Carter WG, Nottenburg C, Wayner EA, Gallatin WM, St John T: Isolation and DNA sequence of a cDNA clone encoding a lymphocyte adhesion receptor for high endothelium. Proc Natl Acad Sci USA 86:4659, 1989
11. Goldstein LA, Butcher EC: Identification of mRNA that encodes an alternative form of H-CAM (CD44) in lymphoid and non-lymphoid tissues. Immunogenetics 32:389, 1990
12. Lokeshwar VB, Bourguignon LYW: Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis. J Biol Chem 266:17983, 1991
13. Camp RL, Kraus TA, Pure E: Variations in the cytoskeletal interaction and posttranslational modification of the CD44 homing receptor in macrophages. J Cell Biol 115:1283, 1991
14. Brown TA, Bouchard T, St John T, Wayner E, Carter WG: Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol 113:207, 1991
15. Stamenkovic L, Aruffo A, Amiot M, Seed B: The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10:343, 1991
16. Dougherty GJ, Lansdorp PM, Cooper DL, Humphries RK: Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells. J Exp Med 174:1, 1991
17. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13, 1991
18. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160, 1992
19. Screaton GR, Bell MV, Bell JI, Jackson DG: The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. J Biol Chem 268:12235, 1993
20. Tölg C, Hofmann M, Herrlich P, Ponta H: Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 21:1225, 1993
21. Haynes BF, Liao HX, Patton KL: The transmembrane hyaluronate receptor (CD44): Multiple functions, multiple forms. Cancer Cells 3:347, 1991
22. Günthert U: CD44: A multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 184:47, 1993
23. Miyake K, Medina KL, Hayashi SI, Ono S, Hamaoka T, Kincade PW: Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med 171:457, 1990
24. Lewinsohn DM. Nagler A. Ginzton N, Greenherg P, Butcher EC: Hematopoietic progenitor cell expression of the H-Cam (CD44) homing-associated adhesion molecule. Blood 75:589, 1990
25. Long MW: Blood cell cytoadhesion molecules. Exp Hematol 20:288, 1992
26. Minguell JJ: Is hyaluronic acid the organizer of the extracellular matrix in bone marrow stroma? Exp Hematol 21:7, 1993
27. Pierres A, Lipsey C, Mawas C, Olive D: A unique CD44 monoclonal antibody identifies a new T cell activation pathway. Eur J Immunol 22:413, 1992
28. Conrad P, Rothman BL, Kelley KA, Blue ML: Mechanism of peripheral T cell activation by coengagement of CD44 and CD2. J Immunol 149:1833, 1992
29. Shimizu Y, van Seventer GA, Siraganian R, Wahl L, Shaw S: Dual role of the CD44 molecule in T-cell adhesion and activation. J Immunol 143:2457, 1989
30. Huet S, Groux H, Caillou B, Valentin H, Prieur AM, Bernard A: CD44 contributes to T cell activation. J Immunol 143:798, 1989
31. Denning SM, Le PT, Singer KH, Haynes BF: Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol 144:7, 1990
32. Sommer F, Huber M, Rollonghoff M, Lohoff M: CD44 plays a co-stimulatory role in murine T cell activation: Ligation of CD44 selectively co-stimulates IL-2 production, but not proliferation in TCR-stimulated murine Th1 cells. Im Immunol 7:1779, 1995
33. Verdrengh M, Holmdahl R, Tarkowski A: Administration of antibodies to hyaluronanreceptor (CD44) delays the start and ameliorates the severity of collagen II arthritis. Scand J Immunol 42:353, 1995
34. Krakauer T: Cell adhesion molecules are co-receptors for staphylococcal enterotoxin B-induced T-cell activation and cytokine production. Immunol Lett 39:121, 1994
35. Rosenman SJ, Ganji AA, Tedder TF, Gallatin WM: Syncapping of human T lymphocyte adhesion/activation molecules and their redistribution during interaction with endothelial cells. J Leukoc Biol 53:1, 1993
36. Rothman BL, Blue ML, Kelley KA, Wunderlich D, Mierz DV, Aune TM: Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44. J Immunol 147:2493, 1991
37. Seth A, Gote L, Nagarkatti M, Nagarkatti PS: T cell receptor independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90Mel-14. Proc Natl Acad Sci USA 88:7877, 1991
38. Levesque MC, Haynes BF: In vitro culture of human peripheral blood monocytes induces hyaluronan binding and upregulates monocyte variant CD44 isoform expression. J Immunol 156:1557, 1996
39. Galluzzo E, Albi N, Fiorucci S, Merigiola C, Ruggeri L, Tosti A, Grossi CE, Velardi A: Involvement of CD44 variant isoforms in hyaluronate adhesion of human activated T cells. Eur J Immunol 25:2932, 1995
40. Rosenberg WM, Prince C, Kaklamanis L, Fox SB, Jackson DG, Simmons DL, Chapman RW, Trowell JM, Jewell DP, Bell JI: Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet 345:1205, 1995
41. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zöller M: Participation of a metastasis-inducing splice variant of CD44 in normal immune response. Science 257:682, 1992
42. Zöller M: Joint features of metastasis formation and lymphocyte maturation and activation. Curr Top Microbiol Immunol 213:215, 1996
43. Moll J, Schmidt A, van der Putten H, Plug R, Ponta H, Herrlich P, Zöller M: Accelerated immune response in transgenic mice expressing rat rCD44v4-v7 on T cells. J Immunol 156:2085, 1996
44. Matzku S, Wenzel A, Liu S, Zöller M: Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies. Cancer Res 49:1294, 1989
45. Spanopoulou E, Giguere V, Grosfeld F: The functional domains of the murine Thy1 gene promoter. Mol Cell Biol 4:2216, 1991
46. Born B, White J, Kappler J, Marrack P: Rearrangement of IgH genes in normal thymocyte development. J Immunol 140:3228, 1988
47. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503, 1975
48. Budd RC, Cerottini JC, Horvati C, Bron C, Pedrazzini T, Howe RC, MacDonald HR: Distinction of virgin and memory T lymphocytes. Stable acquisition of the pgp-1 glycoprotein concomitant with antigenic stimulation. J Immunol 138:3120, 1987
49. Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldmann H: Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312:548, 1984
50. Dialynas DP, Quan ZO, Wall KA, Pierres A, Quintans J, Loken MR, Pierres M, Fitch FW: Characterization of the murine T-cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: Similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol 131:2445, 1983
51. Arnold B, Horstmann U, Kuon W, Burgen HG, Hämmerling GL, Kvist S: Alloreactive cytolytic T cell clones preferentially recognize conformational determinants on histocompatibility antigens: Analysis with genetically engineered hybrid antigens. Proc Natl Acad Sci USA 82:7030, 1985
52. Zöller M, Schuhmacher J, Reed J, Maier-Borst W, Matzku S: Establishment and characterization of monoclonal antibodies against an octahedral Gallium chelate. J Nucl Med 33:1366, 1992
53. Björck L, Kronvall G: Purification and some properties of streptococcal Protein G: A novel IgG binding reagent. J Immunol 133:969, 1984
54. Wysocki LJ, Sato VL: Panning for lymphocytes: A method for cell selection. Proc Natl Acad Sci USA 75:2844, 1978
55. Lefkovits I, Waldmann H: Limiting Dilution Analysis of Cells in the Immune System. Cambridge, MA, Cambridge, 1978
56. Sandmaier BM, Storb R, Appelbaum FR, Gallatin WM: An antibody that facilitates hematopoietic engraftment recognizes CD44. Blood 76:630, 1990
57. Kincade PW, He Q, Ishihara K, Miyake K, Lesley J, Hyman R: CD44 and other cell interaction molecules contributing to B lymphopoesis. Curr Top Microbiol Immunol 184:215, 1993
58. Weber B, Rösel M, Arch R, Möller P, Zöller M: Expression of variant isoforms of CD44 during ontogeny of the rat: Evidence for divergent functions of distinct exon combinations. Differentiation 60:17, 1996
59. Mori T, Tsoi MS, Gillis S, Santos E, Thomas ED, Storb R: Cellular interactions in marrow-grafted patients. I. Impairment of cell mediated lympholysis associated with graft-vs-host disease and the effect of interleukin2. J Immunol 130:712, 1983
60. Jadus MR, Wesic HT: The role of cytokines in graft-versus-host reactions and disease. Bone Marrow Transplant 10:1, 1992
61. Levy RB, Jones M, Hamilton BL, Paupe J, Horowitz T, Riley R: IL-7 drives donor T cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation. J Immunol 154:106, 1995
62. Webb DS, Shimizu Y, vanSeventer GA, Shaw S, Gerrard TL: LFA-3, CD44, and CD45: Physiological triggers of human monocyte TNF and IL-1 release. Science 249:1295, 1990
63. Gruber MF, Webb DSA, Gerrard TL: Stimulation of human monocytes via CD45, CD44 and LFA-3 triggers macrophage-colony-stimulating factor production: Synergism with lipopolysaccharide and IL-1β. J Immunol 148:1113, 1992
64. Noble PW, Lake FR, Henson PM, Riches DW: Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J Clin Invest 91:2368, 1993
65. Zembala M, Siedlar M, Ruggiero I, Wieckiewicz J, Mytar B, Mattei M, Colizzi V: The MHC class-II and CD44 molecules are involved in the induction of tumour necrosis factor (TNF) gene expression by human monocytes stimulated with tumour cells. Int J Cancer 56:269, 1994
66. Weber GF, Ashkar S, Glimcher MJ, Cantor H: Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:5248, 1995
67. Nossal GJ: Negative selection of lymphocytes. Cell 76:229, 1994
68. Ayroldi E, Cannarile L, Ricardi C: Modulation of superantigen-induced T-cell deletion by antibody anti-Pgp-1 (CD44). Immunology 87:191, 1996
69. Rothenberg EV: How T cells count. Science 273:78, 1996
70. Thomas JM, Verbanac KM, Carver FM, Kasten-Jolly J, Haisch CE, Gross U, Smith JP: Veto cells in transplantation tolerance. Clin Transplant 8:195, 1994
71. Hiruma K, Nakamura H, Henkart PA, Gress RE: Clonal deletion of postthymic T cells: Veto cells kill precursor cytotoxic T lymphocytes. J Exp Med 175:863, 1992
72. Starzl TE, Demetris AJ, Murase N, Ilstad S, Ricardi C, Trucco M: Cell migration, chimerism, and graft acceptance. Lancet 339:1579, 1992
73. Talmadge JE: The combination of stem cell transplantation and immunotherapy: Future potential. In Vivo 8:675, 1994
74. Slavin S, Naparstek E, Nagler A, Ackerstein A, Kapelushnik J, Or R: Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes. Exp Hematol 23:1553, 1995
75. Brenner MK, Heslop HE: Graft versus host reactions and bone marrow transplantation. Curr Opin Immunol 3:752, 1991
76. Keleman E, Szebeni J, Petranyi GG: Graft versus host disease in bone marrow transplantation: Experimental, laboratory, and clinical contributions of the last few years. Int Arch Immunol 102:309, 1993
77. Noga SJ, Hess AD: Lymphocyte depletion in bone marrow transplantation: Will modulation of graft-versus-host disease prove to be superior to prevention? Semin Oncol 20:28, 1993 (suppl 6)
78. Lamb LS, Szafer F, Henslee-Downey PJ, Walker M, King S, Godder K, Pati AR, Best R. Steinman L, Geier SS, Gee AP: Characterization of acute bone marrow graft rejection in T cell-depleted partially mismatched related donor bone marrow transplantation. Exp Haematol 23:1595, 1995
79. Rozans MK, Smith BR, Burakoff SJ, Miller RA: Long-lasting deficit of functional helper and killer T cell precursors in human bone marrow transplant recipients revealed by limiting dilution methods. J Immunol 136:4040, 1986
80. Miller RA, Daley J, Ghalie R, Kaizer H: Clonal analysis of T cell deficiencies in autotransplant recipients. Blood 77:1845, 1991
81. Mackall CL, Granger L, Sheard MA, Cepeda R, Gress RE: T-cell regeneration after bone marrow transplantation: Differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 82:2585, 1993
82. Kameoka J, Sato T, Torimoto Y, Sugita K, Soiffer RJ, Schlossman SF, Ritz J, Morimoto C: Differential CD26-mediated activation of the CD3 and CD2 pathways after CD26-depleted allogeneic bone marrow transplantation. Blood 85:1182, 1995